327 related articles for article (PubMed ID: 33181331)
21. PKDL--A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India.
Ganguly S; Saha P; Chatterjee M; Roy S; Ghosh TK; Guha SK; Kundu PK; Bera DK; Basu N; Maji AK
PLoS Negl Trop Dis; 2015; 9(10):e0004138. PubMed ID: 26485704
[TBL] [Abstract][Full Text] [Related]
22. Intralesional sodium stibogluconate under inhaled anesthesia for the treatment of cutaneous leishmaniasis in children: A retrospective cohort.
Renert-Yuval Y; Enk CD; Murad S; Yofe V; Gozal D; Molho-Pessach V
J Am Acad Dermatol; 2019 Oct; 81(4):1013-1015. PubMed ID: 30731176
[No Abstract] [Full Text] [Related]
23. Randomized, double-blind study on intralesional metronidazole versus intralesional sodium stibogluconate in Leishmania donovani cutaneous leishmaniasis.
Somaratne VN; Ranawaka RR; Jayaruwan HM; Wipuladasa DM; de Silva SHP
J Dermatolog Treat; 2019 Feb; 30(1):87-91. PubMed ID: 29764246
[TBL] [Abstract][Full Text] [Related]
24. A Clinicoepidemiological Study of Pediatric Cutaneous Leishmaniasis in Sinjar Province, Iraq.
Hussein NR
Am J Trop Med Hyg; 2019 Nov; 101(5):1111-1113. PubMed ID: 31516113
[TBL] [Abstract][Full Text] [Related]
25. The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.
Asilian A; Sadeghinia A; Faghihi G; Momeni A; Amini Harandi A
Ann Trop Med Parasitol; 2003 Jul; 97(5):493-8. PubMed ID: 12930612
[TBL] [Abstract][Full Text] [Related]
26. Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony.
Faris RM; Jarallah JS; Khoja TA; al-Yamani MJ
Int J Dermatol; 1993 Aug; 32(8):610-2. PubMed ID: 8407083
[TBL] [Abstract][Full Text] [Related]
27. Pediatric cutaneous leishmaniasis in an endemic region in India.
Agrawal S; Khandelwal K; Bumb RA; Oghumu S; Salotra P; Satoskar AR
Am J Trop Med Hyg; 2014 Nov; 91(5):901-4. PubMed ID: 25294618
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial.
Reithinger R; Mohsen M; Wahid M; Bismullah M; Quinnell RJ; Davies CR; Kolaczinski J; David JR
Clin Infect Dis; 2005 Apr; 40(8):1148-55. PubMed ID: 15791515
[TBL] [Abstract][Full Text] [Related]
29. A retrospective study of intravenous sodium stibogluconate alone and in combinations with allopurinol, rifampicin, and an immunomodulator in the treatment of Indian post-kala-azar dermal leishmaniasis.
Ramesh V; Kumar J; Kumar D; Salotra P
Indian J Dermatol Venereol Leprol; 2010; 76(2):138-44. PubMed ID: 20228542
[TBL] [Abstract][Full Text] [Related]
30. A newly emerged cutaneous leishmaniasis focus in central Iran.
Nateghi Rostami M; Saghafipour A; Vesali E
Int J Infect Dis; 2013 Dec; 17(12):e1198-206. PubMed ID: 24011629
[TBL] [Abstract][Full Text] [Related]
31. Treatment failure to sodium stibogluconate in cutaneous leishmaniasis: A challenge to infection control and disease elimination.
Silva H; Liyanage A; Deerasinghe T; Chandrasekara V; Chellappan K; Karunaweera ND
PLoS One; 2021; 16(10):e0259009. PubMed ID: 34679130
[TBL] [Abstract][Full Text] [Related]
32. Case Report: A Single-Center Case Series on Skin Manifestations of Leishmaniasis from a Non-Endemic State in Southern India.
Tharakan SJ; Peter Cv D; Karthik R; Rupa V; Rose W; Thomas M; Manuel M; Rupali P; Pulimood S; Rao Ajjampur SS
Am J Trop Med Hyg; 2020 Dec; 104(3):928-933. PubMed ID: 33377447
[TBL] [Abstract][Full Text] [Related]
33. Efficacy, Safety and Cost-Effectiveness of Thermotherapy in the Treatment of
Refai WF; Madarasingha NP; Sumanasena B; Weerasingha S; De Silva A; Fernandopulle R; Satoskar AR; Karunaweera ND
Am J Trop Med Hyg; 2017 Oct; 97(4):1120-1126. PubMed ID: 28820681
[No Abstract] [Full Text] [Related]
34. Pediatric Cutaneous Leishmaniasis in Turkey: A Retrospective Analysis of 8047 Cases.
Solmaz A; An İ; Acar U; Aksoy M
Acta Dermatovenerol Croat; 2024 Mar; 32(1):44-49. PubMed ID: 38946187
[TBL] [Abstract][Full Text] [Related]
35. Clinical Response with intralesional Amphotericin B in the treatment of old world cutaneous leishmaniasis: a preliminary report.
Mushtaq S; Dogra D; Dogra N
Dermatol Ther; 2016 Nov; 29(6):398-405. PubMed ID: 27477764
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of a new focus of localized cutaneous leishmaniasis in Himachal Pradesh.
Sharma NL; Mahajan VK; Negi AK
J Commun Dis; 2005 Dec; 37(4):275-9. PubMed ID: 17278657
[TBL] [Abstract][Full Text] [Related]
37. Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia.
Bermúdez H; Rojas E; Garcia L; Desjeux P; Dujardin JC; Boelaert M; Chappuis F
Ann Trop Med Parasitol; 2006 Oct; 100(7):591-600. PubMed ID: 16989685
[TBL] [Abstract][Full Text] [Related]
38. Clinical study of cutaneous leishmaniasis in the Kashmir Valley.
Wani GM; Ahmad SM; Khursheed B
Indian Dermatol Online J; 2015; 6(6):387-92. PubMed ID: 26753136
[TBL] [Abstract][Full Text] [Related]
39. Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers.
Solomon M; Pavlotzky F; Barzilai A; Schwartz E
J Am Acad Dermatol; 2013 Feb; 68(2):284-9. PubMed ID: 22858005
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis.
Munir A; Janjua SA; Hussain I
Acta Dermatovenerol Croat; 2008; 16(2):60-4. PubMed ID: 18541100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
